What is Scotts Miracle Gr's earnings per share (EPS)?

Scotts Miracle Gr (SMG) reported diluted earnings per share of $2.47 for fiscal year 2025. This represents a 504.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Scotts Miracle Gr Financials

SMG

Trailing 12 months to June 27, 2026

Revenue $3.5B +4.6% YoY

Net Income $73.9M +39.2% YoY

EPS (Diluted) $1.18 +47.5% YoY

Free Cash Flow $263.3M +7.6% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 27, 2026 Reported Aug 5, 2026 Currency USD FYE September

Scotts Miracle Gr (SMG) reported $3.5B in revenue over the twelve months to Jun 27, 2026, up 4.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SMG FY2025 2026-08-29

Margin recovery, not top-line expansion, is the dominant mechanic: lower sales now produce operating profit and positive cash generation.

From FY2023 to FY2025, gross margin expanded from 18.5% to 30.6% while sales remained broadly lower, pointing to changed costs or product mix rather than scale-driven absorption. Operating cash flow fell from $667.5M in FY2024 to $371.3M in FY2025 even as net income returned to positive territory; cash still exceeded earnings, but the conversion cushion narrowed.

The recovery reaches operating profit: operating margin moved from -4.9% in FY2023 to 10.5% in FY2025 without corresponding top-line momentum. Free cash flow remained positive at $273.9M, showing that reinvestment still left cash after operations, although less than operating cash generation.

The company is reducing debt but remains liability-heavy. FY2025 liabilities of $3.10B exceeded assets of $2.74B, leaving negative equity; meanwhile, the 1.3x current ratio indicates near-term assets modestly exceed near-term obligations, a different signal from the weaker total capital position.

Financial Health Signals

Financial Health Score 40/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Scotts Miracle Gr's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Scotts Miracle Gr has an operating margin of 10.5%, meaning the company retains $11 of operating profit per $100 of revenue. This results in a moderate score of 45/100, indicating healthy but not exceptional operating efficiency. This is up from 5.9% the prior year.

Growth

Scotts Miracle Gr's revenue declined 3.9% year-over-year, from $3.6B to $3.4B. This contraction results in a growth score of 25/100.

Leverage

Liquidity

Scotts Miracle Gr's current ratio of 1.27 indicates adequate short-term liquidity, earning a score of 32/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Scotts Miracle Gr converts 8.0% of revenue into free cash flow ($273.9M). This strong cash generation earns a score of 71/100.

Returns

Altman Z-Score Grey Zone

2.60

Scotts Miracle Gr scores 2.60, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

Scotts Miracle Gr passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.56x

For every $1 of reported earnings, Scotts Miracle Gr generates $2.56 in operating cash flow ($371.3M OCF vs $145.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

2.78x

Scotts Miracle Gr earns $2.78 in operating income for every $1 of interest expense ($358.6M vs $128.8M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.4B

YoY-3.9%

5Y CAGR-3.7%

10Y CAGR+1.2%

Scotts Miracle Gr generated $3.4B in revenue in fiscal year 2025. This represents a decrease of 3.9% from the prior year.

EBITDA

$436.2M

YoY+50.7%

5Y CAGR-8.5%

10Y CAGR+3.6%

Scotts Miracle Gr's EBITDA was $436.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 50.7% from the prior year.

Net Income

$145.2M

YoY+516.0%

5Y CAGR-17.8%

10Y CAGR-1.0%

Scotts Miracle Gr reported $145.2M in net income in fiscal year 2025. This represents an increase of 516.0% from the prior year.

EPS (Diluted)

$2.47

YoY+504.9%

5Y CAGR-18.4%

10Y CAGR-0.4%

Scotts Miracle Gr earned $2.47 per diluted share (EPS) in fiscal year 2025. This represents an increase of 504.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$273.9M

YoY-53.1%

5Y CAGR-11.2%

10Y CAGR+4.0%

Scotts Miracle Gr generated $273.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 53.1% from the prior year.

Cash & Debt

$32.8M

YoY-54.2%

5Y CAGR+14.6%

10Y CAGR-4.3%

Scotts Miracle Gr held $32.8M in cash against $2.0B in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.64

YoY0.0%

5Y CAGR-18.5%

10Y CAGR+3.8%

Scotts Miracle Gr paid $2.64 per share in dividends in fiscal year 2025. That is unchanged from the prior year.

Shares Outstanding

58M

YoY+1.0%

5Y CAGR+0.8%

10Y CAGR-0.6%

Scotts Miracle Gr had 58M shares outstanding in fiscal year 2025. This represents an increase of 1.0% from the prior year.

Margins & Returns

Gross Margin

30.6%

YoY+6.7pp

5Y CAGR-2.0pp

10Y CAGR+3.7pp

Scotts Miracle Gr's gross margin was 30.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 6.7 percentage points from the prior year.

Operating Margin

10.5%

YoY+4.6pp

5Y CAGR-3.7pp

10Y CAGR+2.1pp

Scotts Miracle Gr's operating margin was 10.5% in fiscal year 2025, reflecting core business profitability. This is up 4.6 percentage points from the prior year.

Net Margin

4.3%

YoY+5.2pp

5Y CAGR-5.1pp

10Y CAGR-1.0pp

Scotts Miracle Gr's net profit margin was 4.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.2 percentage points from the prior year.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending

$34.8M

YoY+0.6%

5Y CAGR-2.6%

10Y CAGR-0.5%

Scotts Miracle Gr invested $34.8M in research and development in fiscal year 2025. This represents an increase of 0.6% from the prior year.

Share Buybacks

$18.4M

YoY+260.8%

5Y CAGR-19.1%

10Y CAGR+2.2%

Scotts Miracle Gr spent $18.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 260.8% from the prior year.

Capital Expenditures

$97.4M

YoY+16.0%

5Y CAGR+9.2%

10Y CAGR+4.7%

Scotts Miracle Gr invested $97.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 16.0% from the prior year.

SMG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SMG quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$3.5B	$3.4B-3.9%	$3.6B0.0%	$3.6B-9.5%	$3.9B-20.3%	$4.9B+19.2%	$4.1B+30.9%	$3.2B+18.5%	$2.7B+0.8%	$2.6B+5.4%	$2.5B-16.9%	$3.0B+6.2%	$2.8B+2.4%	$2.8B+0.1%	$2.8B-1.0%	$2.8B
Cost of Revenue	$2.4B	$2.3B-10.3%	$2.6B-3.3%	$2.7B-6.3%	$2.9B-15.7%	$3.4B+23.9%	$2.8B+30.0%	$2.1B+19.8%	$1.8B+6.5%	$1.7B+4.3%	$1.6B+2.7%	$1.6B-7.8%	$1.7B-5.9%	$1.8B-1.1%	$1.8B+2.5%	$1.8B
Gross Profit	$1.1B	$1.0B+22.8%	$850.5M+29.4%	$657.3M-24.7%	$872.9M-40.6%	$1.5B+9.1%	$1.3B+32.1%	$1.0B+17.9%	$864.6M-11.1%	$972.6M+8.0%	$900.3M+11.0%	$810.8M-8.9%	$890.1M-9.0%	$978.2M+2.3%	$956.6M-5.2%	$1.0B
R&D Expenses	N/A	$34.8M+0.6%	$34.6M-3.1%	$35.7M-21.2%	$45.3M-0.2%	$45.4M+14.4%	$39.7M+0.3%	$39.6M-6.8%	$42.5M+6.5%	$39.9M+10.8%	$36.0M-1.4%	$36.5M-20.7%	$46.0M-0.9%	$46.4M-7.4%	$50.1M-1.6%	$50.9M
SG&A Expenses	$618.1M	$603.4M+7.9%	$559.0M+1.4%	$551.3M-10.1%	$613.0M-17.6%	$743.5M-1.9%	$757.8M+26.0%	$601.3M+11.3%	$540.1M-2.0%	$550.9M+6.4%	$518.0M+6.0%	$488.8M-13.8%	$567.1M-14.0%	$659.6M-6.2%	$703.3M+2.5%	$686.3M
Operating Income	$382.5M	$358.6M+71.7%	$208.8M+219.7%	-$174.4M+59.8%	-$434.0M-160.0%	$723.0M+23.5%	$585.2M+42.9%	$409.6M+105.9%	$198.9M-54.1%	$433.4M-3.2%	$447.6M+76.4%	$253.8M-10.5%	$283.7M-8.6%	$310.5M+28.7%	$241.2M-12.2%	$274.8M
Interest Expense	$113.0M	$128.8M-18.9%	$158.8M-10.8%	$178.1M+50.8%	$118.1M+49.7%	$78.9M-0.9%	$79.6M-21.8%	$101.8M+17.8%	$86.4M+13.5%	$76.1M+21.0%	$62.9M+28.9%	$48.8M+3.2%	$47.3M-20.1%	$59.2M-4.2%	$61.8M+21.2%	$51.0M
Income Tax	$94.4M	$76.5M+577.0%	$11.3M+115.4%	-$73.2M+39.3%	-$120.6M-175.5%	$159.8M+29.2%	$123.7M-14.6%	$144.9M+1317.6%	-$11.9M-110.2%	$116.6M-15.3%	$137.6M+80.3%	$76.3M-4.9%	$80.2M-12.7%	$91.9M+35.5%	$67.8M-18.0%	$82.7M
Net Income	$73.9M	$145.2M+516.0%	-$34.9M+90.8%	-$380.1M+13.1%	-$437.5M-185.4%	$512.5M+32.3%	$387.4M-15.9%	$460.7M+623.2%	$63.7M-70.8%	$218.3M-30.8%	$315.3M+97.3%	$159.8M-4.0%	$166.5M+3.4%	$161.1M+51.3%	$106.5M-36.6%	$167.9M
EPS (Diluted)	$1.18	$2.47+504.9%	-$0.61+91.0%	-$6.79+13.8%	-$7.88-187.9%	$8.96+31.6%	$6.81-16.7%	$8.18+630.4%	$1.12-69.1%	$3.63-28.7%	$5.09+98.1%	$2.57-3.0%	$2.65+3.1%	$2.57+50.3%	$1.71-32.7%	$2.54

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$1.2B-19.7%	$1.5B+311.8%	$354.4M-28.8%	$497.5M-57.1%	$1.2B-16.6%	$1.4B+279.1%	$366.6M-11.6%	$414.7M
Cost of Revenue	$805.0M-5.2%	$849.0M+221.1%	$264.4M-40.6%	$445.0M-43.3%	$784.6M-6.9%	$842.3M+204.4%	$276.7M-35.2%	$427.3M
Gross Profit	$365.9M-40.1%	$610.5M+588.3%	$88.7M+116.9%	$40.9M-89.0%	$372.7M-31.2%	$542.1M+512.5%	$88.5M+400.0%	-$29.5M
SG&A Expenses	$145.6M-26.9%	$199.2M+87.9%	$106.0M-36.6%	$167.3M+15.5%	$144.8M-18.6%	$177.8M+56.7%	$113.5M-3.5%	$117.6M
Operating Income	$169.6M-57.8%	$401.8M+1943.1%	-$21.8M+87.0%	-$167.1M-175.3%	$221.8M-36.6%	$349.7M+863.5%	-$45.8M+78.8%	-$216.1M
Interest Expense	$28.0M-10.5%	$31.3M+15.1%	$27.2M+2.6%	$26.5M-16.7%	$31.8M-13.1%	$36.6M+8.0%	$33.9M+2.4%	$33.1M
Income Tax	$51.6M-49.2%	$101.6M+755.5%	-$15.5M+64.2%	-$43.3M-173.0%	$59.3M-30.5%	$85.3M+444.0%	-$24.8M+63.6%	-$68.2M
Net Income	$112.2M-53.0%	$238.6M+290.9%	-$125.0M+17.7%	-$151.9M-201.9%	$149.1M-31.4%	$217.5M+412.9%	-$69.5M+71.5%	-$244.0M
EPS (Diluted)	$1.90-53.0%	$4.04+287.0%	-$2.16+16.9%	-$2.60-202.4%	$2.54-31.7%	$3.72+407.4%	-$1.21+71.5%	-$4.25

Not reported in any period shown, so not listed: R&D Expenses.

SMG Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SMG quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$2.7B-4.5%	$2.9B-15.9%	$3.4B-20.6%	$4.3B-10.5%	$4.8B+42.0%	$3.4B+11.6%	$3.0B-0.8%	$3.1B+11.2%	$2.7B-0.3%	$2.8B+9.0%	$2.5B+22.8%	$2.1B+6.3%	$1.9B-6.6%	$2.1B+1.1%	$2.1B
Current Assets	$940.3M-4.1%	$980.4M-29.9%	$1.4B-29.5%	$2.0B-2.1%	$2.0B+66.4%	$1.2B+16.8%	$1.0B+17.6%	$885.7M+0.5%	$881.7M-14.6%	$1.0B-7.7%	$1.1B+19.7%	$935.0M+6.1%	$881.0M-11.9%	$1.0B+0.8%	$992.5M
Cash & Equivalents	$32.8M-54.2%	$71.6M+124.5%	$31.9M-63.2%	$86.8M-64.4%	$244.1M+1370.5%	$16.6M-11.7%	$18.8M-44.5%	$33.9M-71.9%	$120.5M+321.3%	$28.6M-43.7%	$50.8M-21.7%	$64.9M-50.0%	$129.8M-1.6%	$131.9M+0.8%	$130.9M
Inventory	$542.7M-7.6%	$587.5M-33.3%	$880.3M-34.5%	$1.3B+19.3%	$1.1B+81.2%	$621.9M+15.1%	$540.3M+12.2%	$481.4M+18.1%	$407.5M+3.2%	$394.7M-0.3%	$395.8M+2.8%	$385.1M+18.5%	$324.9M-21.7%	$414.9M+7.2%	$387.0M
Accounts Receivable	$160.8M-9.0%	$176.8M-41.9%	$304.2M+1.7%	$299.0M-38.1%	$483.4M+1.8%	$474.8M+112.1%	$223.9M-0.9%	$226.0M+14.3%	$197.7M+55.7%	$127.0M-19.5%	$157.7M-29.6%	$224.0M+8.4%	$206.6M-37.6%	$330.9M+2.3%	$323.5M
Goodwill	$243.9M0.0%	$243.9M0.0%	$243.9M-4.0%	$254.0M-58.0%	$605.2M+11.2%	$544.1M+1.0%	$538.7M-0.8%	$543.0M+23.0%	$441.6M+18.7%	$371.9M+31.6%	$282.5M+29.0%	$219.0M-30.5%	$315.1M+1.8%	$309.4M+0.1%	$309.1M
Total Liabilities	$3.1B-5.0%	$3.3B-11.4%	$3.7B-11.3%	$4.1B+9.6%	$3.8B+41.4%	$2.7B+16.1%	$2.3B-14.4%	$2.7B+29.2%	$2.1B+3.2%	$2.0B+6.7%	$1.9B+27.0%	$1.5B+21.6%	$1.2B-16.7%	$1.5B-1.3%	$1.5B
Current Liabilities	$739.7M-1.4%	$750.3M-3.0%	$773.7M-19.7%	$963.9M-15.5%	$1.1B+20.0%	$950.4M+53.2%	$620.5M+1.3%	$612.7M+12.5%	$544.5M-23.0%	$707.1M+14.3%	$618.6M+13.6%	$544.7M+6.8%	$509.8M+17.6%	$433.6M-7.5%	$468.6M
Long-Term Debt	$2.0B-5.7%	$2.2B-15.0%	$2.6B-9.5%	$2.8B+26.4%	$2.2B+53.7%	$1.5B-4.5%	$1.5B-19.1%	$1.9B+49.7%	$1.3B+22.0%	$1.0B+0.6%	$1.0B+48.0%	$692.4M+44.8%	$478.1M-38.8%	$781.1M-1.4%	$791.8M
Total Equity	-$357.5M+8.5%	-$390.6M-46.1%	-$267.3M-281.0%	$147.7M-85.4%	$1.0B+45.3%	$697.2M-3.0%	$718.7M+102.7%	$354.6M-45.3%	$648.8M-9.3%	$715.2M+15.2%	$620.7M+12.1%	$553.7M-22.1%	$710.5M+18.0%	$601.9M+7.5%	$559.8M
Retained Earnings	$294.7M-3.0%	$303.8M-38.1%	$490.9M-51.9%	$1.0B-36.4%	$1.6B+29.9%	$1.2B-3.1%	$1.3B+38.6%	$919.9M-6.0%	$978.2M+10.9%	$881.8M+28.9%	$684.2M+7.4%	$636.9M-9.5%	$703.4M+11.6%	$630.2M+5.2%	$599.2M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$3.2B-7.2%	$3.4B+12.5%	$3.0B+10.6%	$2.7B-11.3%	$3.1B-12.6%	$3.5B+11.6%	$3.2B+10.4%	$2.9B
Current Assets	$1.3B-16.8%	$1.6B+29.0%	$1.3B+33.7%	$940.3M-26.7%	$1.3B-25.8%	$1.7B+34.5%	$1.3B+31.1%	$980.4M
Cash & Equivalents	$27.7M+346.8%	$6.2M-25.3%	$8.3M-74.7%	$32.8M-17.2%	$39.6M+355.2%	$8.7M+52.6%	$5.7M-92.0%	$71.6M
Inventory	$481.4M-30.8%	$696.0M-17.8%	$846.7M+56.0%	$542.7M+11.8%	$485.4M-31.6%	$709.6M-16.0%	$844.9M+43.8%	$587.5M
Accounts Receivable	$713.0M-7.0%	$766.7M+295.6%	$193.8M+20.5%	$160.8M-70.5%	$545.7M-28.9%	$767.8M+343.8%	$173.0M-2.1%	$176.8M
Goodwill	$243.9M0.0%	$243.9M0.0%	$243.9M0.0%	$243.9M0.0%	$243.9M0.0%	$243.9M0.0%	$243.9M0.0%	$243.9M
Total Liabilities	$3.4B-8.7%	$3.7B+4.6%	$3.5B+14.0%	$3.1B-5.0%	$3.3B-14.8%	$3.8B+4.9%	$3.6B+11.9%	$3.3B
Current Liabilities	$1.1B-12.9%	$1.3B+36.8%	$932.4M+26.1%	$739.7M-7.4%	$798.6M-21.1%	$1.0B+48.1%	$683.8M-8.9%	$750.3M
Long-Term Debt	$1.8B-11.2%	$2.1B-8.1%	$2.3B+9.8%	$2.0B-4.1%	$2.1B-14.3%	$2.5B-5.4%	$2.6B+21.3%	$2.2B
Total Equity	-$208.7M+27.2%	-$286.5M+42.8%	-$500.6M-40.0%	-$357.5M-109.2%	-$170.9M+41.1%	-$290.1M+39.5%	-$479.5M-22.8%	-$390.6M
Retained Earnings	$404.3M+22.1%	$331.0M+152.3%	$131.2M-55.5%	$294.7M-39.3%	$485.2M+29.8%	$373.7M+90.9%	$195.8M-35.5%	$303.8M

SMG Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SMG quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$369.3M	$371.3M-44.4%	$667.5M+25.7%	$531.0M+511.6%	-$129.0M-147.5%	$271.5M-51.3%	$558.0M+146.0%	$226.8M-33.8%	$342.5M-5.7%	$363.2M+48.9%	$244.0M-1.2%	$246.9M+2.5%	$240.9M-29.6%	$342.0M+122.9%	$153.4M+25.6%	$122.1M
Capital Expenditures	$106.0M	$97.4M+16.0%	$84.0M-9.5%	$92.8M-18.2%	$113.5M+6.2%	$106.9M+70.5%	$62.7M+47.9%	$42.4M-37.8%	$68.2M-2.0%	$69.6M+19.4%	$58.3M-5.5%	$61.7M-29.6%	$87.6M+45.8%	$60.1M-13.4%	$69.4M-4.5%	$72.7M
Free Cash Flow	$263.3M	$273.9M-53.1%	$583.5M+33.2%	$438.2M+280.7%	-$242.5M-247.3%	$164.6M-66.8%	$495.3M+168.6%	$184.4M-32.8%	$274.3M-6.6%	$293.6M+58.1%	$185.7M+0.3%	$185.2M+20.8%	$153.3M-45.6%	$281.9M+235.6%	$84.0M+70.0%	$49.4M
Investing Cash Flow	-$154.2M	-$112.1M-11.7%	-$100.4M-52.8%	-$65.7M+76.8%	-$283.2M+47.4%	-$538.6M-1248.4%	$46.9M-81.6%	$255.2M+143.9%	-$580.7M-2692.4%	$22.4M+116.7%	-$134.4M+74.9%	-$536.4M-244.7%	-$155.6M-142.4%	-$64.2M+15.2%	-$75.7M-149.3%	$153.5M
Financing Cash Flow	-$237.6M	-$294.0M+44.3%	-$527.9M-1.5%	-$520.1M-303.7%	$255.3M-48.3%	$494.0M+181.4%	-$607.1M-22.3%	-$496.5M-428.4%	$151.2M+147.7%	-$316.8M-146.0%	-$128.8M-146.2%	$278.9M+324.4%	-$124.3M+55.7%	-$280.6M-253.8%	-$79.3M+65.6%	-$230.7M
Dividends Paid	$154.1M	$154.3M+2.0%	$151.3M+1.5%	$149.1M-10.3%	$166.2M+16.2%	$143.0M-65.2%	$411.2M+230.3%	$124.5M+3.8%	$120.0M-0.2%	$120.3M+3.2%	$116.6M+4.8%	$111.3M-51.8%	$230.8M+162.9%	$87.8M+16.4%	$75.4M+11.0%	$67.9M
Share Buybacks	$12.1M	$18.4M+260.8%	$5.1M-45.2%	$9.3M-96.4%	$257.9M+99.5%	$129.3M+143.0%	$53.2M+1616.1%	$3.1M-99.1%	$327.7M+28.4%	$255.2M+85.7%	$137.4M+828.4%	$14.8M-87.7%	$120.0M	$0-100.0%	$17.5M-95.1%	$358.7M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	$345.6M+57.1%	$220.0M+159.4%	-$370.4M-312.8%	$174.1M-61.7%	$454.4M+141.6%	$188.1M+142.2%	-$445.3M-475.8%	$118.5M
Capital Expenditures	$24.5M+31.7%	$18.6M-7.0%	$20.0M-53.4%	$42.9M+153.8%	$16.9M+103.6%	$8.3M-71.7%	$29.3M+76.5%	$16.6M
Free Cash Flow	$321.1M+59.4%	$201.4M+151.6%	-$390.4M-397.6%	$131.2M-70.0%	$437.5M+143.3%	$179.8M+137.9%	-$474.6M-565.8%	$101.9M
Investing Cash Flow	-$56.7M-140.3%	-$23.6M-8.3%	-$21.8M+58.2%	-$52.1M-105.9%	-$25.3M-121.9%	-$11.4M+51.1%	-$23.3M-14.2%	-$20.4M
Financing Cash Flow	-$270.0M-36.0%	-$198.6M-154.1%	$366.8M+370.1%	-$135.8M+65.7%	-$396.1M-133.3%	-$169.8M-141.6%	$407.7M+232.9%	-$306.8M
Dividends Paid	$38.9M+0.3%	$38.8M+1.3%	$38.3M+0.5%	$38.1M+1.6%	$37.5M-5.3%	$39.6M+1.0%	$39.2M+4.3%	$37.6M
Share Buybacks	$500K-84.8%	$3.3M-60.2%	$8.3M	$0-100.0%	$100K-96.3%	$2.7M-82.7%	$15.6M+15500.0%	$100K

SMG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SMG quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	30.6%+6.7pp	23.9%+5.4pp	18.5%-3.7pp	22.2%-7.6pp	29.8%-2.8pp	32.6%+0.3pp	32.3%-0.2pp	32.5%-4.3pp	36.8%+0.9pp	35.9%+9.0pp	26.9%-4.5pp	31.3%-3.9pp	35.3%+0.7pp	34.5%-1.5pp	36.0%
Operating Margin	10.5%+4.6pp	5.9%+10.8pp	-4.9%+6.2pp	-11.1%-25.7pp	14.7%+0.5pp	14.2%+1.2pp	13.0%+5.5pp	7.5%-8.9pp	16.4%-1.5pp	17.9%+9.5pp	8.4%-1.6pp	10.0%-1.2pp	11.2%+2.5pp	8.7%-1.1pp	9.8%
Net Margin	4.3%+5.2pp	-1.0%+9.7pp	-10.7%+0.5pp	-11.2%-21.6pp	10.4%+1.0pp	9.4%-5.2pp	14.6%+12.2pp	2.4%-5.9pp	8.3%-4.3pp	12.6%+7.3pp	5.3%-0.6pp	5.9%+0.1pp	5.8%+2.0pp	3.8%-2.2pp	6.0%
Return on Equity	N/A	N/A	N/A	-296.2%-346.8pp	50.6%-5.0pp	55.6%-8.5pp	64.1%+46.1pp	18.0%-15.7pp	33.7%-10.4pp	44.1%+18.3pp	25.8%-4.3pp	30.1%+7.4pp	22.7%+5.0pp	17.7%-12.3pp	30.0%
Return on Assets	5.3%+6.5pp	-1.2%+9.9pp	-11.1%-0.9pp	-10.2%-20.9pp	10.7%-0.8pp	11.5%-3.8pp	15.2%+13.1pp	2.1%-5.9pp	8.0%-3.5pp	11.4%+5.1pp	6.3%-1.8pp	8.1%-0.2pp	8.3%+3.2pp	5.1%-3.0pp	8.2%
Current Ratio	1.270.0x	1.31-0.5x	1.81-0.2x	2.06+0.3x	1.77+0.5x	1.28-0.4x	1.68+0.2x	1.45-0.2x	1.62+0.2x	1.46-0.3x	1.81+0.1x	1.720.0x	1.73-0.6x	2.31+0.2x	2.12
Debt-to-Equity	N/A	N/A	N/A	19.13+16.9x	2.21+0.1x	2.090.0x	2.12-3.2x	5.31+3.4x	1.94+0.5x	1.44-0.2x	1.65+0.4x	1.25+0.6x	0.67-0.6x	1.30-0.1x	1.41
FCF Margin	8.0%-8.4pp	16.4%+4.1pp	12.3%+18.5pp	-6.2%-9.5pp	3.3%-8.7pp	12.0%+6.2pp	5.8%-4.5pp	10.3%-0.8pp	11.1%+3.7pp	7.4%+1.3pp	6.1%+0.7pp	5.4%-4.8pp	10.2%+7.1pp	3.0%+1.3pp	1.8%

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	31.2%-10.6pp	41.8%+16.8pp	25.0%+16.8pp	8.2%-23.9pp	32.1%-6.9pp	39.0%+14.9pp	24.1%+31.3pp	-7.1%
Operating Margin	14.5%-13.1pp	27.5%+33.7pp	-6.2%+27.4pp	-33.6%-52.7pp	19.1%-6.0pp	25.2%+37.6pp	-12.5%+39.6pp	-52.1%
Net Margin	9.6%-6.8pp	16.4%+51.6pp	-35.3%-4.7pp	-30.5%-43.4pp	12.9%-2.8pp	15.7%+34.6pp	-19.0%+39.9pp	-58.8%
Return on Assets	3.5%-3.5pp	7.0%+11.1pp	-4.1%+1.4pp	-5.5%-10.4pp	4.8%-1.3pp	6.2%+8.3pp	-2.2%+6.3pp	-8.5%
Current Ratio	1.21-0.1x	1.27-0.1x	1.35+0.1x	1.27-0.3x	1.61-0.1x	1.71-0.2x	1.88+0.6x	1.31
FCF Margin	27.4%+13.6pp	13.8%	-110.2%	26.4%-11.4pp	37.7%+24.8pp	12.9%	-129.5%	24.6%

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: FCF Margin.

Note: Shareholder equity is negative (-$357.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

$1.4B

$7.2B

$7.5B

$1.3B

$19.0B

Where Scotts Miracle Gr Ranks

Frequently Asked Questions

What is Scotts Miracle Gr's annual revenue?

Scotts Miracle Gr (SMG) reported $3.4B in total revenue for fiscal year 2025. This represents a -3.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Scotts Miracle Gr's revenue growing?

Scotts Miracle Gr (SMG) revenue declined by 3.9% year-over-year, from $3.6B to $3.4B in fiscal year 2025.

Is Scotts Miracle Gr profitable?

Yes, Scotts Miracle Gr (SMG) reported a net income of $145.2M in fiscal year 2025, with a net profit margin of 4.3%.

What is Scotts Miracle Gr's EBITDA?

Scotts Miracle Gr (SMG) had EBITDA of $436.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Scotts Miracle Gr have?

As of fiscal year 2025, Scotts Miracle Gr (SMG) had $32.8M in cash and equivalents against $2.0B in long-term debt.

What is Scotts Miracle Gr's gross margin?

Scotts Miracle Gr (SMG) had a gross margin of 30.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Scotts Miracle Gr's operating margin?

Scotts Miracle Gr (SMG) had an operating margin of 10.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Scotts Miracle Gr's net profit margin?

Scotts Miracle Gr (SMG) had a net profit margin of 4.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Scotts Miracle Gr pay dividends?

Yes, Scotts Miracle Gr (SMG) paid $2.64 per share in dividends during fiscal year 2025.

What is Scotts Miracle Gr's free cash flow?

Scotts Miracle Gr (SMG) generated $273.9M in free cash flow during fiscal year 2025. This represents a -53.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Scotts Miracle Gr's operating cash flow?

Scotts Miracle Gr (SMG) generated $371.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Scotts Miracle Gr's total assets?

Scotts Miracle Gr (SMG) had $2.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Scotts Miracle Gr's capital expenditures?

Scotts Miracle Gr (SMG) invested $97.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Scotts Miracle Gr spend on research and development?

Scotts Miracle Gr (SMG) invested $34.8M in research and development during fiscal year 2025.

Does Scotts Miracle Gr buy back shares?

Yes, Scotts Miracle Gr (SMG) spent $18.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Scotts Miracle Gr have outstanding?

Scotts Miracle Gr (SMG) had 58M shares outstanding as of fiscal year 2025.

What is Scotts Miracle Gr's current ratio?

Scotts Miracle Gr (SMG) had a current ratio of 1.27 as of fiscal year 2025, which is considered adequate.

What is Scotts Miracle Gr's return on assets (ROA)?

Scotts Miracle Gr (SMG) had a return on assets of 5.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Scotts Miracle Gr's debt-to-equity ratio negative or not reported?

Scotts Miracle Gr (SMG) has negative shareholder equity of -$357.5M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Scotts Miracle Gr's Altman Z-Score?

Scotts Miracle Gr (SMG) has an Altman Z-Score of 2.60, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Scotts Miracle Gr's Piotroski F-Score?

Scotts Miracle Gr (SMG) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Scotts Miracle Gr's earnings high quality?

Scotts Miracle Gr (SMG) has an earnings quality ratio of 2.56x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Scotts Miracle Gr cover its interest payments?

Scotts Miracle Gr (SMG) has an interest coverage ratio of 2.78x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Scotts Miracle Gr?

Scotts Miracle Gr (SMG) scores 40 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.